Bicara Therapeutics Inc. - 10-Q Filing

Bicara Therapeutics Inc. filed its quarterly report for the period ended March 31, 2026, disclosing financial results and operational updates as a clinical-stage biopharmaceutical company.

SEC EDGAR ·

Tickers: $BCAX

Read the full article at SEC EDGAR

More Regulatory news